Press Release BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 15 hours ago
Press Release BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET Aug 3